Literature DB >> 27918782

Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?

Harold J Burstein1, Deborah Schrag2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27918782     DOI： 10.1001/jama.2016.18979

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes.

Authors:  Hajime Uno; Deborah Schrag; Dae Hyun Kim; Dejun Tang; Lu Tian; Hope S Rugo; Lee-Jen Wei
Journal:  JNCI Cancer Spectr       Date:  2019-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.